Spots Global Cancer Trial Database for multidrug resistance
Every month we try and update this database with for multidrug resistance cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pilot Study of 18F Fluoropaclitaxel (FPAC) | NCT00572598 | Breast Cancer | 4- [F-18] fluor... | 18 Years - 90 Years | Virginia Commonwealth University | |
Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies | NCT00256191 | Neoplasms Hodgkin's Disea... Non-Hodgkin's L... | TPI 287 Injecti... | 18 Years - 85 Years | Cortice Biosciences, Inc. | |
A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | NCT00001339 | Adrenal Cortica... | doxorubicin, vi... | - | National Institutes of Health Clinical Center (CC) | |
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | NCT00001383 | Breast Cancer Cancer Carcinoma, Rena... Lymphoma Ovarian Cancer | PSC 833 paclitaxel | - | National Institutes of Health Clinical Center (CC) | |
Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer | NCT00001493 | Breast Neoplasm... Neoplasm Metast... | peripheral bloo... | - | National Institutes of Health Clinical Center (CC) | |
A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | NCT00001339 | Adrenal Cortica... | doxorubicin, vi... | - | National Institutes of Health Clinical Center (CC) | |
Pilot Study of 18F Fluoropaclitaxel (FPAC) | NCT00572598 | Breast Cancer | 4- [F-18] fluor... | 18 Years - 90 Years | Virginia Commonwealth University | |
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | NCT00001383 | Breast Cancer Cancer Carcinoma, Rena... Lymphoma Ovarian Cancer | PSC 833 paclitaxel | - | National Institutes of Health Clinical Center (CC) | |
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 | NCT00001302 | Breast Cancer Kidney Neoplasm Lymphoma Neoplasm Metast... Ovarian Cancer | PSC 833 | - | National Institutes of Health Clinical Center (CC) |